Skip to content

Polycystic Ovary Syndrome and Physical Exercise

Cardiovascular Risk in Polycystic Ovary Syndrome: Effect of Different Physical Exercise Programs on the Hormonal, Cardiovascular, Metabolic, Reproductive and Quality of Life Aspects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4qxgjh
Enrollment
Unknown
Registered
2016-12-26
Start date
2010-01-11
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Control group: 15 women with polycystic ovary syndrome will receive standard advice for regular physical activity. The control group will be instructed to accumulate 30 minutes of moderate aerobic act
Behavioural
G11.427.590.530.698.277

Sponsors

Universidade Federal do Rio Grande do Norte - UFRN
Lead Sponsor
Hospital Universitário Onofre Lopes – HUOL-UFRN
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 34 Years

Inclusion criteria

Inclusion criteria: Diagnosis of polycystic ovary syndrome according to the Rotterdam criteria

Exclusion criteria

Exclusion criteria: Other disorders such as nonclassic congenital adrenal hyperplasia, thyroid dysfunction, and hyperprolactinemia; renal or hepatic dysfunction; or use of medications known to affect reproductive, cardiovascular or metabolic function

Design outcomes

Primary

MeasureTime frame
Increased maximal oxygen uptake after 16 weeks of physical training, verified by ergospirometry, from of a change of at least 10% in the pre- and post-intervention measurements

Secondary

MeasureTime frame
Improvement of the reproductive, hormonal and metabolic aspects after 16 weeks of physical training, verified by ovarian morphological analysis and levels of luteinizing hormone, follicle-stimulating hormone, progesterone, 17-hydroxyprogesterone, total testosterone, dehydroepiandrosterone sulfate, prolactin, sex hormone-binding globulin, total cholesterol, high density lipoprotein, triglycerides, urea, creatinine, C-reactive protein, plasminogen activator inhibitor-1, glucose and insulin, from the observation of a significant change in the pre- and post-intervention measurements;Improvement of the cardiovascular aspect after 16 weeks of physical training, verified by blood pressure and heart rate, from the observation of a significant change in the pre- and post-intervention measurements;Improvement of body composition after 16 weeks of physical training, verified by body mass, body mass index, and waist and hip circumference, from the observation of a significant change in the pre- and post-intervention measurements;Improvement in quality of life after 16 weeks of physical training, verified by quality of life questionnaire, from the observation of a significant change in the pre- and post-intervention measurements

Countries

Brazil

Contacts

Public ContactEduardo;George Costa;de Azevedo

Universidade Federal do Rio Grande do Norte - UFRN;Universidade Federal do Rio Grande do Norte - UFRN

ecc@ufrnet.br;georgedantas.faimer@gmail.com+55(84)32153451;+55(84)32153431

Outcome results

None listed

Source: REBEC (via WHO ICTRP)